Katz N, Kopecky EA, O?Connor M, Brown RH, Fleming AB. A phase 3, multicenter, randomized, double-blind, placebo-controlled, safety, tolerability, and efficacy study of Xtampza ER in patients with moderate-to-severe chronic low back pain. Pain. 2015;156(12):2458?2467. doi:10.1097/j.pain.0000000000000315

Leave a Reply